Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

Wegovy. Zepbound… and yes, Ozempic. A Kaiser Family Foundation poll found that one in 8 American adults reported trying a GLP-1 medication. “Body by Ozempic” has become a punchline on red ...

CLEVELAND, Ohio -- Berberine, a natural compound found in various plants, has gained attention on social media platforms, particularly TikTok, where it’s being hailed as “nature’s Ozempic.” ...

The rise of GLP-1 agonist weight loss drugs has prompted the supplement industry to launch a bevy of “natural alternatives” to pharmaceutical compounds like Ozempic and Wegovy. But do they ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist, or GLP-1 RA, known as semaglutide. The latest FDA approval makes the medication the first GLP-1 treatment option for people with type ...

Type 2 diabetes is a leading cause of chronic kidney disease, which affects more than 1 in 7 U.S. adults. The new approval allows doctors to prescribe Ozempic specifically to lower the risk of ...

About 215,000 used GLP-1 drugs, while the rest were taking various other diabetes medications. Though semaglutides like Ozempic and Wegovy dominate the market in the U.S., Al-Aly and his team ...